The steady stream of biotechs aiming to list on the Nasdaq has continued, with Attovia Therapeutics and Braveheart Bio the ...

MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval in the US, after getting the go-ahead ...

Just a few months after it was formed by a merger of two psychedelic drug developers, AtaiBeckley has been snapped up by Eli ...

A national newborn screening programme for spinal muscular atrophy (SMA) will be rolled out in England, to give babies the ...

Thousands of people in England and Wales with a type of chronic heart failure (CHF) could soon be eligible for treatment with ...

The European Commission has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, making it the first oral ...

Any uncertainty about whether the second Trump administration would prioritise healthcare fraud enforcement was put to rest ...

Fresh from signing an alliance with Novartis, Chai Discovery has raised $400 million in a third-round financing to support ...

Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of ...

An alarming study has found that people who suffer a serious heart attack are more likely to have micro and nanoplastics ...

After a delay, Eisai and Biogen have won FDA approval for their new subcutaneous formulation of Alzheimer's disease therapy ...

New biotech Avere Therapeutics has taken a fast-track to becoming a publicly listed company by merging with NextCure, with a ...